These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 19487179)
1. Geographic and temporal trends of transmitted HIV-1 drug resistance among antiretroviral-naïve subjects screening for two clinical trials in North America and Western Europe. Rahim S; Fredrick LM; da Silva BA; Bernstein B; King MS HIV Clin Trials; 2009; 10(2):94-103. PubMed ID: 19487179 [TBL] [Abstract][Full Text] [Related]
2. Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States. Ross LL; Shortino D; Shaefer MS AIDS Res Hum Retroviruses; 2018 Aug; 34(8):672-679. PubMed ID: 29732898 [TBL] [Abstract][Full Text] [Related]
3. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic. Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489 [TBL] [Abstract][Full Text] [Related]
4. Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis. Rhee SY; Blanco JL; Jordan MR; Taylor J; Lemey P; Varghese V; Hamers RL; Bertagnolio S; Rinke de Wit TF; Aghokeng AF; Albert J; Avi R; Avila-Rios S; Bessong PO; Brooks JI; Boucher CA; Brumme ZL; Busch MP; Bussmann H; Chaix ML; Chin BS; D'Aquin TT; De Gascun CF; Derache A; Descamps D; Deshpande AK; Djoko CF; Eshleman SH; Fleury H; Frange P; Fujisaki S; Harrigan PR; Hattori J; Holguin A; Hunt GM; Ichimura H; Kaleebu P; Katzenstein D; Kiertiburanakul S; Kim JH; Kim SS; Li Y; Lutsar I; Morris L; Ndembi N; Ng KP; Paranjape RS; Peeters M; Poljak M; Price MA; Ragonnet-Cronin ML; Reyes-Terán G; Rolland M; Sirivichayakul S; Smith DM; Soares MA; Soriano VV; Ssemwanga D; Stanojevic M; Stefani MA; Sugiura W; Sungkanuparph S; Tanuri A; Tee KK; Truong HM; van de Vijver DA; Vidal N; Yang C; Yang R; Yebra G; Ioannidis JP; Vandamme AM; Shafer RW PLoS Med; 2015 Apr; 12(4):e1001810. PubMed ID: 25849352 [TBL] [Abstract][Full Text] [Related]
5. Surveillance of antiretroviral drug resistance mutations in untreated young children living in the Central African Republic. Charpentier C; Gody JC; Tisserand P; Matta M; Péré H; Fournier J; Mbitikon O; Bélec L Antivir Ther; 2011; 16(8):1347-50. PubMed ID: 22155917 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patients. Clevenbergh P; Cua E; Dam E; Durant J; Schmit JC; Boulme R; Cottalorda J; Beyou A; Schapiro JM; Clavel F; Dellamonica P HIV Clin Trials; 2002; 3(1):36-44. PubMed ID: 11819184 [TBL] [Abstract][Full Text] [Related]
7. Limited evolution but increasing trends of primary non-nucleoside reverse transcriptase inhibitor resistance mutations in therapy-naive HIV-1-infected individuals in India. Neogi U; Gupta S; Palchaudhuri R; Rao SD; Shastri S; Diwan V; Laishram RS; De Costa A; Shet A Antivir Ther; 2014; 19(8):813-8. PubMed ID: 24699043 [TBL] [Abstract][Full Text] [Related]
8. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil. Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362 [TBL] [Abstract][Full Text] [Related]
9. Limited increase in primary HIV-1C drug resistance mutations in treatment naïve individuals in Ethiopia. Huruy K; Maier M; Mulu A; Liebert UG J Med Virol; 2015 Jun; 87(6):978-84. PubMed ID: 25649964 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals. Balotta C; Berlusconi A; Pan A; Violin M; Riva C; Colombo MC; Gori A; Papagno L; Corvasce S; Mazzucchelli R; Facchi G; Velleca R; Saporetti G; Galli M; Rusconi S; Moroni M Antivir Ther; 2000 Mar; 5(1):7-14. PubMed ID: 10846586 [TBL] [Abstract][Full Text] [Related]
11. Applying Next-Generation Sequencing to Track HIV-1 Drug Resistance Mutations Circulating in Portugal. Pimentel V; Pingarilho M; Sebastião CS; Miranda M; Gonçalves F; Cabanas J; Costa I; Diogo I; Fernandes S; Costa O; Corte-Real R; Martins MRO; Seabra SG; Abecasis AB; Gomes P Viruses; 2024 Apr; 16(4):. PubMed ID: 38675962 [TBL] [Abstract][Full Text] [Related]
12. Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations. Vega Y; Delgado E; Fernández-García A; Cuevas MT; Thomson MM; Montero V; Sánchez M; Sánchez AM; Pérez-Álvarez L; PLoS One; 2015; 10(5):e0125699. PubMed ID: 26010948 [TBL] [Abstract][Full Text] [Related]
13. Surveillance of HIV type 1 drug resistance among naive patients from Venezuela. Castillo J; Comegna M; Quijada W; Jauvin V; Pinson P; Masquelier B; Fleury H; Castro E AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1329-33. PubMed ID: 19954301 [TBL] [Abstract][Full Text] [Related]
14. Screening for antiretroviral drug resistance among treatment-naive human immunodeficiency virus type 1-infected individuals in Lebanon. Mokhbat JM; Melhem NM; El-Khatib Z; Zalloua P J Infect Dev Ctries; 2014 Mar; 8(3):339-48. PubMed ID: 24619266 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study. Viani RM; Peralta L; Aldrovandi G; Kapogiannis BG; Mitchell R; Spector SA; Lie YS; Weidler JM; Bates MP; Liu N; Wilson CM; J Infect Dis; 2006 Dec; 194(11):1505-9. PubMed ID: 17083034 [TBL] [Abstract][Full Text] [Related]
16. Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world. Frentz D; Boucher CA; van de Vijver DA AIDS Rev; 2012; 14(1):17-27. PubMed ID: 22297501 [TBL] [Abstract][Full Text] [Related]
17. Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV. Climaco-Arvizu S; Flores-López V; González-Torres C; Gaytán-Cervantes FJ; Hernández-García MC; Zárate-Segura PB; Chávez-Torres M; Tesoro-Cruz E; Pinto-Cardoso SM; Bekker-Méndez VC BMC Infect Dis; 2022 May; 22(1):447. PubMed ID: 35538426 [TBL] [Abstract][Full Text] [Related]
18. Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe. Hofstra LM; Sauvageot N; Albert J; Alexiev I; Garcia F; Struck D; Van de Vijver DAMC; Åsjö B; Beshkov D; Coughlan S; Descamps D; Griskevicius A; Hamouda O; Horban A; Van Kasteren M; Kolupajeva T; Kostrikis LG; Liitsola K; Linka M; Mor O; Nielsen C; Otelea D; Paraskevis D; Paredes R; Poljak M; Puchhammer-Stöckl E; Sönnerborg A; Staneková D; Stanojevic M; Van Laethem K; Zazzi M; Zidovec Lepej S; Boucher CAB; Schmit JC; Wensing AMJ; ; Puchhammer-Stockl E; Sarcletti M; Schmied B; Geit M; Balluch G; Vandamme AM; Vercauteren J; Derdelinckx I; Sasse A; Bogaert M; Ceunen H; De Roo A; De Wit S; Echahidi F; Fransen K; Goffard JC; Goubau P; Goudeseune E; Yombi JC; Lacor P; Liesnard C; Moutschen M; Pierard D; Rens R; Schrooten Y; Vaira D; Vandekerckhove LPR; Van den Heuvel A; Van Der Gucht B; Van Ranst M; Van Wijngaerden E; Vandercam B; Vekemans M; Verhofstede C; Clumeck N; Van Laethem K; Beshkov D; Alexiev I; Lepej SZ; Begovac J; Kostrikis L; Demetriades I; Kousiappa I; Demetriou V; Hezka J; Linka M; Maly M; Machala L; Nielsen C; Jørgensen LB; Gerstoft J; Mathiesen L; Pedersen C; Nielsen H; Laursen A; Kvinesdal B; Liitsola K; Ristola M; Suni J; Sutinen J; Descamps D; Assoumou L; Castor G; Grude M; Flandre P; Storto A; Hamouda O; Kücherer C; Berg T; Braun P; Poggensee G; Däumer M; Eberle J; Heiken H; Kaiser R; Knechten H; Korn K; Müller H; Neifer S; Schmidt B; Walter H; Gunsenheimer-Bartmeyer B; Harrer T; Paraskevis D; Hatzakis A; Zavitsanou A; Vassilakis A; Lazanas M; Chini M; Lioni A; Sakka V; Kourkounti S; Paparizos V; Antoniadou A; Papadopoulos A; Poulakou G; Katsarolis I; Protopapas K; Chryssos G; Drimis S; Gargalianos P; Xylomenos G; Lourida G; Psichogiou M; Daikos GL; Sipsas NV; Kontos A; Gamaletsou MN; Koratzanis G; Sambatakou H; Mariolis H; Skoutelis A; Papastamopoulos V; Georgiou O; Panagopoulos P; Maltezos E; Coughlan S; De Gascun C; Byrne C; Duffy M; Bergin C; Reidy D; Farrell G; Lambert J; O'Connor E; Rochford A; Low J; Coakely P; O'Dea S; Hall W; Mor O; Levi I; Chemtob D; Grossman Z; Zazzi M; de Luca A; Balotta C; Riva C; Mussini C; Caramma I; Capetti A; Colombo MC; Rossi C; Prati F; Tramuto F; Vitale F; Ciccozzi M; Angarano G; Rezza G; Kolupajeva T; Vasins O; Griskevicius A; Lipnickiene V; Schmit JC; Struck D; Sauvageot N; Hemmer R; Arendt V; Michaux C; Staub T; Sequin-Devaux C; Wensing AMJ; Boucher CAB; van de Vijver DAMC; van Kessel A; van Bentum PHM; Brinkman K; Connell BJ; van der Ende ME; Hoepelman IM; van Kasteren M; Kuipers M; Langebeek N; Richter C; Santegoets RMWJ; Schrijnders-Gudde L; Schuurman R; van de Ven BJM; Åsjö B; Kran AB; Ormaasen V; Aavitsland P; Horban A; Stanczak JJ; Stanczak GP; Firlag-Burkacka E; Wiercinska-Drapalo A; Jablonowska E; Maolepsza E; Leszczyszyn-Pynka M; Szata W; Camacho R; Palma C; Borges F; Paixão T; Duque V; Araújo F; Otelea D; Paraschiv S; Tudor AM; Cernat R; Chiriac C; Dumitrescu F; Prisecariu LJ; Stanojevic M; Jevtovic D; Salemovic D; Stanekova D; Habekova M; Chabadová Z; Drobkova T; Bukovinova P; Shunnar A; Truska P; Poljak M; Lunar M; Babic D; Tomazic J; Vidmar L; Vovko T; Karner P; Garcia F; Paredes R; Monge S; Moreno S; Del Amo J; Asensi V; Sirvent JL; de Mendoza C; Delgado R; Gutiérrez F; Berenguer J; Garcia-Bujalance S; Stella N; de Los Santos I; Blanco JR; Dalmau D; Rivero M; Segura F; Elías MJP; Alvarez M; Chueca N; Rodríguez-Martín C; Vidal C; Palomares JC; Viciana I; Viciana P; Cordoba J; Aguilera A; Domingo P; Galindo MJ; Miralles C; Del Pozo MA; Ribera E; Iribarren JA; Ruiz L; de la Torre J; Vidal F; Clotet B; Albert J; Heidarian A; Aperia-Peipke K; Axelsson M; Mild M; Karlsson A; Sönnerborg A; Thalme A; Navér L; Bratt G; Karlsson A; Blaxhult A; Gisslén M; Svennerholm B; Bergbrant I; Björkman P; Säll C; Mellgren Å; Lindholm A; Kuylenstierna N; Montelius R; Azimi F; Johansson B; Carlsson M; Johansson E; Ljungberg B; Ekvall H; Strand A; Mäkitalo S; Öberg S; Holmblad P; Höfer M; Holmberg H; Josefson P; Ryding U Clin Infect Dis; 2016 Mar; 62(5):655-663. PubMed ID: 26620652 [TBL] [Abstract][Full Text] [Related]
19. Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi. Petch LA; Hoffman IF; Jere CS; Kazembe PN; Martinson FE; Chilongozi D; Fiscus SA; Cohen MS AIDS Res Hum Retroviruses; 2005 Sep; 21(9):799-805. PubMed ID: 16218804 [TBL] [Abstract][Full Text] [Related]
20. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China. Zhao B; Han X; Dai D; Liu J; Ding H; Xu J; Chu Z; Bice T; Diao Y; Shang H AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1047-53. PubMed ID: 21417755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]